Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merus NV

56.21
+0.20000.36%
Post-market: 56.210.00000.00%19:43 EDT
Volume:761.91K
Turnover:43.22M
Market Cap:4.19B
PE:-13.57
High:57.70
Open:56.04
Low:56.01
Close:56.01
Loading ...

Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Cross Country Healthcare (CCRN) and GoodRx Holdings (GDRX)

TIPRANKS
·
08 May

Analysts Have Conflicting Sentiments on These Healthcare Companies: Merus (MRUS), Staar Surgical (STAA) and Inogen (INGN)

TIPRANKS
·
08 May

Merus NV reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Merus Q1 EPS $(1.40) Misses $(1.10) Estimate, Sales $26.49M Beat $7.82M Estimate

Benzinga
·
08 May

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Walgreens Boots Alliance (WBA) and Merus (MRUS)

TIPRANKS
·
24 Apr

Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting

GlobeNewswire
·
23 Apr

Is Merus (NASDAQ:MRUS) the Best High Short Interest Stock to Buy Now?

Insider Monkey
·
18 Apr

Analysts’ Top Healthcare Picks: Merus (MRUS), Corcept Therapeutics (CORT)

TIPRANKS
·
17 Apr

Strength Seen in BioMarin (BMRN): Can Its 6.3% Jump Turn into More Strength?

Zacks
·
10 Apr

Merus Is Maintained at Buy by Needham

Dow Jones
·
09 Apr

Merus Price Target Maintained With a $109.00/Share by Guggenheim

Dow Jones
·
28 Mar

Merus Price Target Maintained With a $109.00/Share by Guggenheim

Dow Jones
·
18 Mar

Merus Is Maintained at Buy by B of A Securities

Dow Jones
·
11 Mar

Stifel Nicolaus Sticks to Its Buy Rating for Merus (MRUS)

TIPRANKS
·
06 Mar

Merus Price Target Maintained With a $85.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Mar

Merus Is Maintained at Buy by Needham

Dow Jones
·
28 Feb

Truist Financial Sticks to Their Buy Rating for Merus (MRUS)

TIPRANKS
·
28 Feb

Merus Nv : Bmo Raises Target Price to $96 From $95

THOMSON REUTERS
·
28 Feb

Merus NV reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Merus N.V. (MRUS) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
28 Feb